Peer-reviewed veterinary case report
Evaluation of Fortetropin in geriatric and senior dogs with reduced mobility.
- Journal:
- The Canadian veterinary journal = La revue veterinaire canadienne
- Year:
- 2022
- Authors:
- Hetrick, Katie et al.
- Affiliation:
- Department of Clinical Sciences College of Veterinary Medicine · United States
- Species:
- dog
Abstract
As pets age, quality of life and mobility can be affected by pain of osteoarthritis and age-related muscle atrophy (sarcopenia). The purpose of this randomized, double-blinded, placebo-controlled study was to evaluate the effects of Fortetropin, a nonthermal-pasteurized, freeze-dried, fertilized egg yolk product, on mobility in senior dogs. Mobility scores were calculated using a standardized and validated client-based survey: the Liverpool Osteoarthritis in Dogs (LOAD) questionnaire. Results showed mild, but statistically significant, improvement of the mobility scores for the treatment group at both week 6 (= 0.03) and week 12 (= 0.006) compared to the baseline score. No statistical improvement was noted at any time in the placebo group or between the treatment and placebo group.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://pubmed.ncbi.nlm.nih.gov/36185794/